Entasis Therapeutics Holdings Inc.
ETTXDelisted Jul 11, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724344
Entasis Therapeutics Holdings Inc. was delisted on Jul 11, 2022; its insiders filed their last Form 4 on Jul 13, 2022; 27 institutions reported holding it in 13F filings for Q2 2022, worth $12.5M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Entasis Therapeutics Holdings Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q1 2021
- Shares held
- 3.33M
- −1.03M (−23.7%) vs. Q1 2021
- Total value
- $8.89M
- −$449.0K (−4.8%) vs. Q1 2021
- New holders
- 7
- 4 more added
- Sold out
- 8
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 27 | $12.5M |
| Q1 2022 | 22 | $5.77M |
| Q4 2021 | 28 | $7.24M |
| Q3 2021 | 29 | $11.3M |
| Q2 2021 | 24 | $8.89M |
| Q1 2021 | 25 | $9.34M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Entasis Therapeutics Holdings Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 1,020,748 | $2.73M | 0.02% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 590,602 | $1.58M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 419,997 | $1.12M | 0.00% | +214,831+104.7% | Added |
| Renaissance Technologies LLC | 391,629 | $1.05M | 0.00% | −394,977−50.2% | Reduced |
| Two Sigma Investments, LP | 164,229 | $438.0K | 0.00% | +124,868+317.2% | Added |
| Two Sigma Advisers, LP | 162,942 | $435.0K | 0.00% | +162,942 | New |
| Alberta Investment Management Corp | 130,000 | $347.0K | 0.00% | +130,000 | New |
| Bridgeway Capital Management, LLC | 110,000 | $294.0K | 0.01% | −10,000−8.3% | Reduced |
| Geode Capital Management, LLC | 81,121 | $216.0K | 0.00% | +28,424+53.9% | Added |
| Janney Montgomery Scott LLC | 69,487 | $186.0K | 0.00% | −1,443−2.0% | Reduced |
| State Street Corp | 39,205 | $105.0K | 0.00% | +39,205 | New |
| BlackRock Inc. | 32,763 | $88.0K | 0.00% | +26,336+409.8% | Added |
| Acadian Asset Management LLC | 31,793 | $84.0K | 0.00% | +31,793 | New |
| Occudo Quantitative Strategies LP | 23,058 | $62.0K | 0.01% | −5,973−20.6% | Reduced |
| Susquehanna Fundamental Investments, LLC | 22,094 | $59.0K | 0.00% | −19,783−47.2% | Reduced |
| Northern Trust Corp | 20,874 | $56.0K | 0.00% | 00.0% | Unchanged |
| Jaffetilchin Investment Partners, LLC | 11,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 4,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,100 | $6.00K | 0.00% | +2,100 | New |
| Wells Fargo & Company | 1,574 | $4.00K | 0.00% | −1,997−55.9% | Reduced |
| Bollard Group LLC | 1,448 | $4.00K | 0.00% | 00.0% | Unchanged |
| Trustcore Financial Services, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| UBS Group AG | 103 | $0 | 0.00% | +103 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 0 | $0 | 0.00% | −1,176,378−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −91,725−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −68,574−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13,918−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −10,064−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −566−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −112−100.0% | Sold out |